Author Archive: AZBio

Hope for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer

Posted on by

Genentech’s Tecentriq in Combination With Abraxane Improves Outcomes as an Initial Treatment for People With PD-L1-Positive Metastatic Triple-Negative Breast Cancer

– Tecentriq combination first immunotherapy regimen to demonstrate positive Phase III results in breast cancer –

– Tecentriq and nab-paclitaxel significantly reduced the risk of disease worsening or death in both the intention-to-treat and PD-L1-positive populations –

– Clinically meaningful overall survival improvement in the PD-L1-positive population at this interim analysis –

– Data are being presented at the European Society for Medical Oncology (ESMO) 2018 Congress, featured in the press program and simultaneously published in the New England Journal of Medicine on October 20, 2018 –

Continue reading→

‘Leading women’ of biotech share insights

Posted on by

Gathered on the 20th floor of a Phoenix skyscraper on a Monday evening, nearly 40 women – and a few brave men – looked out over the valley and shared their “no boundaries” spirit. They came to connect on the topic of women’s leadership in the biotech industry in Arizona at an Arizona Bioscience Week event, “Leading Women: Biotech and Beyond.”Continue reading→

Announcing the 2018 AZBio Trailblazers

Posted on by

The 2018 AZBio Trailblazer Honorees are: Senator Nancy Barto, Senator Sean Bowie, Senator Kate Brophy McGee, Representative Douglass Coleman, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, Representative Mark Finchem, Representative Maria Syms, and  Representative Jeff Weninger.

Senator Kimberly Yee will be honored with the Chairman’s Award.

Continue reading→